MedTrace Logo

Glulisine Pre- and Postmeal

NCT00290043 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2010-12-06

No results posted yet for this study

Summary

To investigate in type 1 diabetic patients the glucodynamic response to HMR1964 insulin and RHI (HOE31HPR100) injected subcutaneously before and after a standard meal

Conditions

  • Diabetes Mellitus Type 1

Interventions

DRUG

Insulin glulisine

Sponsors & Collaborators

Principal Investigators

  • Klaus Rave, Dr. · Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-12-31
Completion
2002-03-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00290043 on ClinicalTrials.gov